DNER and colitis: This hypothesis is supported by the therapeutic effects of JQ1 in mice with DSS- and TNBS-induced colitis [16], as well as by the ability of the small molecule MS402, another selective inhibitor of the first bromodomain of BET proteins, to ameliorate T cell transfer-induced colitis in mice [23].